Liminatus Pharma (LIMN) Stock Chart & Stock Price History $4.83 +0.13 (+2.77%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsFDA EventsSEC FilingsTrendsBuy This Stock Liminatus Pharma Stock Price Performance The Liminatus Pharma (LIMN) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 30.30%, reflecting recent market activity. As of the latest close, Liminatus Pharma traded at $4.70 with a market cap of $122.25 million and volume of 214,984 shares. Receive LIMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-18.55%1 Month Performance-30.30% LIMN Stock Chart for Thursday, August, 7, 2025 LIMN Chart by TradingView Liminatus Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$4.70$4.83+2.77%$4.87$4.70128,616 shs$125.63 million08/06/2025$4.94$4.70-4.86%$5.06$4.60214,984 shs$122.25 million08/05/2025$5.09$4.94-2.95%$5.18$4.64229,670 shs$128.51 million08/04/2025$5.93$5.09-14.17%$6.31$4.20829,298 shs$132.39 million08/01/2025$6.27$5.93-5.42%$6.28$5.85171,387 shs$154.24 million07/31/2025$6.78$6.27-7.52%$6.84$6.10211,118 shs$163.08 million07/30/2025$6.69$6.78+1.35%$7.10$6.66316,940 shs$176.38 million07/29/2025$8.08$6.69-17.20%$8.06$6.63502,501 shs$174.01 million07/28/2025$8.71$8.08-7.23%$8.89$7.70712,493 shs$210.16 million07/25/2025$8.47$8.71+2.83%$9.38$7.90970,079 shs$226.55 million Get the Latest News and Ratings for LIMN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$6.47$8.47+30.91%$8.70$7.1311.39 million shs$220.35 million07/23/2025$5.78$6.47+11.94%$7.19$6.23762,931 shs$168.29 million07/22/2025$5.58$5.78+3.58%$7.46$5.551.10 million shs$150.34 million07/21/2025$5.42$5.58+2.95%$5.91$5.44401,894 shs$145.14 million07/18/2025$5.47$5.42-0.91%$5.78$5.25263,480 shs$140.97 million07/17/2025$5.40$5.47+1.30%$6.06$5.30379,702 shs$142.30 million07/16/2025$5.59$5.40-3.40%$5.70$5.25212,589 shs$140.45 million07/15/2025$6.33$5.59-11.69%$6.37$5.52141,707 shs$145.42 million07/14/2025$6.65$6.33-4.81%$6.90$6.00138,957 shs$164.68 million07/11/2025$7.20$6.65-7.64%$7.26$6.33180,160 shs$173 million07/10/2025$5.22$7.20+37.93%$7.45$5.82822,339 shs$187.27 million07/09/2025$6.28$5.22-16.88%$6.36$5.05369,649 shs$135.77 million07/08/2025$6.93$6.28-9.38%$8.10$5.92384,740 shs$163.37 million07/07/2025$9.02$6.93-23.17%$9.00$6.80218,015 shs$180.25 million Related Companies aTyr Pharma Stock Chart Savara Stock Chart Arvinas Stock Chart Cullinan Therapeutics Stock Chart Gossamer Bio Stock Chart SNDL Stock Chart CryoPort Stock Chart PureTech Health Stock Chart Kodiak Sciences Stock Chart Tectonic Therapeutic Stock Chart Receive LIMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Liminatus Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LIMN) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liminatus Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Liminatus Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIMN Stock Alerts